Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiation decomposition of technetium-99m radiopharmaceuticals. [Glucnates, pyrophosphates, and serum albumins]

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6168703

Technetium-99m radiopharmaceuticals are shown to be subject to autoradiation-induced decomposition, which results in increasing abundance of pertechnetate in the preparation. This autodecomposition is catalyzed by the presence of oxygen, although the removal of oxygen does not prevent its occurrence. The initial appearance of pertechnetate in the radiopharmaceutical is shown to be a function of the amount of radioactivity, the quantity of stannous ion used, and the ratio of /sup 99m/Tc to total technetium in the preparation.

Research Organization:
Health Sciences Centre, Winnipeg, Manitoba
OSTI ID:
6168703
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 20:2; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions
Journal Article · Mon Jun 01 00:00:00 EDT 1987 · J. Nucl. Med.; (United States) · OSTI ID:6331857

Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits
Journal Article · Sat Oct 31 23:00:00 EST 1981 · Am. J. Hosp. Pharm.; (United States) · OSTI ID:5393397

Tc-99m sulfur colloid radiopharmaceuticals
Patent · Mon Jan 02 23:00:00 EST 1978 · OSTI ID:5113940